Please login to the form below

Not currently logged in
Email:
Password:

Patients Who

This page shows the latest Patients Who news and features for those working in and with pharma, biotech and healthcare.

CHMP backs Sanofi’s all-oral sleeping sickness drug

CHMP backs Sanofi’s all-oral sleeping sickness drug

Vertex Pharma got the okay to extend the use of its Orkambi (lumacaftor/ivacaftor) cystic fibrosis drug to include patients aged 2 to 5 years old who have two copies of ... the F508del mutation, while Horizon Pharma’s Ravicti (glycerol phenylbutyrate)

Latest news

  • Abbott’s wearable glucose monitor to be available across England Abbott’s wearable glucose monitor to be available across England

    By April next year, all type 1 diabetes patients (who qualifies in line with clinical guidelines) will have access to the tech on prescription, he says. ... Simon Stevens added: “Increasingly the NHS is going to be offering patients this sort of

  • FDA green lights BMS’ multiple myeloma combo FDA green lights BMS’ multiple myeloma combo

    Empliciti was initially approved back in 2015 to treat refractory/relapsing multiple myeloma patients who have received between one and three prior treatments as part of a triple combination treatment. ... Darzalex has picked up a number of indications,

  • Soon-Shiong presents first data on cancer memory vaccine at SITC Soon-Shiong presents first data on cancer memory vaccine at SITC

    NK) cells, tumour antigens and drugs achieved tumour responses in heavily pre-treated patients with advanced cases of triple-negative breast cancer, head and neck cancer, and pancreatic cancer. ... The cocktail achieved disease control in four out of

  • FDA clears first-line use for J&J’s myeloma drug Darzalex FDA clears first-line use for J&J’s myeloma drug Darzalex

    The company’s Janssen unit says Darzalex (daratumumab) has been given the nod for use alongside Takeda’s Velcade (bortezomib), melphalan and prednisone (VMP) for newly-diagnosed myeloma patients who are ... to be approved for patients with newly

  • The Final Frontier The Final Frontier

    But let’s talk about gabapentin. In Canada and the US, gabapentin is indicated as an adjunctive therapy for patients with epilepsy, who are not adequately controlled with conventional therapy. ... But what I do know is that the legalisation of medical

More from news
Approximately 1 fully matching, plus 1,102 partially matching documents found.

Latest Intelligence

  • Key considerations for disease- modifying Parkinson’s disease trials Key considerations for disease- modifying Parkinson’s disease trials

    Based on literature, education will help to maintain high adherence. Patients who received education were 96% adherent at six months; with no education, adherence was 58.5% at six months.

  • Nudge-nudge, think-think Nudge-nudge, think-think

    It’s a classic ‘nudge’. The principle is at the root of KOL work – but it applies equally to patients. ... A good example of this is international work to support diabetes patients who recognise Ramadan and want to fast during the Holy Month.

  • Retaining reader value in plain language summaries of clinical studies Retaining reader value in plain language summaries of clinical studies

    Previously their output has been almost exclusively for a scientific audience; they are not accustomed to presenting their findings to readers who do not share the same base understanding. ... To help with this last point the EMA has proposed that, early

  • Tackling a formidable foe Tackling a formidable foe

    Unfortunately, there is still lots to be done, particularly for the patients who have progressive forms of MS where there is a high unmet need. ... In patients who respond well to the treatment, we are practically stopping the disease.

  • The future of medicine has to be data-driven The future of medicine has to be data-driven

    Next-Generation DNA Sequencing (NGS) technology is the latest medical advancement to help decipher patients’DNA. ... specific patient is similar to that of 10, 000 other patients who received treatment A or B that saved them.

More from intelligence
Approximately 0 fully matching, plus 101 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 13 partially matching documents found.

Latest from PMHub

  • World Diabetes Day: Interaction and impact of diabetes on mental health

    Bearing this in mind, it is important to identify and support patients who have developed psychosocial problems early on in their diabetes, as it can affect their ability to make lifestyle ... and Skłodowska, Z., 2009. Serious diabetes-specific

  • The gene therapy revolution

    How will patients with long-term conditions be selected for treatment, what counselling will be needed before and after treatment? ... How should patients be selected for treatment, who comes first, and who makes these decisions?

  • How digital content is helping physicians curb the opioid abuse epidemic

    On one hand are the patients who are physically suffering, desperate for relief. ... On the other hand are the prescribers who are driven to help their patients but finding that their pain management protocols are now complicated by what the national

More from PMHub
Approximately 0 fully matching, plus 3 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Bedrock Healthcare Communications

Bedrock Healthcare Communications is a privately owned, award winning communications agency that creates and delivers highly effective, insight driven medical...

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award
The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
artificial-intelligence-in-healthcare.jpg
Artificial Intelligence in Healthcare
Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...

Infographics